Evidence map›Paper›PMID 24731946›Full record

ArticleExperimental neurology2014

Glial cell line-derived neurotrophic factor promotes increased phenotypic marker expression in femoral sensory and motor-derived Schwann cell cultures.

Nithya J Jesuraj, Laura M Marquardt, Jasmine A Kwasa, Shelly E Sakiyama-Elbert

Open access · greenAbstract read
In one paragraph

Article in Experimental neurology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Optogenetic and Endogenous Modulation of CaInternational journal of molecular sciences · 2025
    Review
  2. Regulatory Effects of Astragaloside IV on Hyperglycemia-Induced Mitophagy in Schwann Cells.Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nithya J JesurajDepartment of Biomedical Engineering, Washington University, St. Louis, MO 63130, USA.
Laura M MarquardtDepartment of Biomedical Engineering, Washington University, St. Louis, MO 63130, USA.
Jasmine A KwasaDepartment of Biomedical Engineering, Washington University, St. Louis, MO 63130, USA.
Shelly E Sakiyama-ElbertDepartment of Biomedical Engineering, Washington University, St. Louis, MO 63130, USA; Division of Plastic and Reconstructive Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, MO 63110, USA. Electronic address: sakiyama@wustl.edu.
Washington University in St. Louis · US

Funding

THE EFFECTS OF GDNF ON PERIPHERAL NERVE REGENERATIONR01NS051706 · NINDS · WASHINGTON UNIVERSITY · PI MACKINNON, SUSAN E, SAKIYAMA-ELBERT, SHELLY ELESE · 2006 to 2016
$4.0M
NINDS NIH HHS NS051706NINDS NIH HHS R01 NS051706
6 · The paper itself

Abstract

Schwann cells (SCs) secrete growth factors and extracellular matrix molecules that promote neuronal survival and help guide axons during regeneration. Transplantation of SCs is a promising strategy for enhancing peripheral nerve regeneration. However, we and others have shown that after long-term in vitro expansion, SCs revert to a de-differentiated state similar to the phenotype observed after injury. In vivo, glial cell-line derived neurotrophic factor (GDNF) may guide the differentiation of SCs to remyelinate regenerating axons. Therefore, we hypothesized that exogenous GDNF may guide the differentiation of SCs into their native phenotypes in vitro through stimulation of GDNF family receptor (GFR)α-1. When activated in SCs, GFRα-1 promotes phosphorylation of Fyn, a Src family tyrosine kinase responsible for mediating downstream signaling for differentiation and proliferation. In this study, SCs harvested from the sensory and motor branches of rat femoral nerve were expanded in vitro and then cultured with 50 or 100ng/mL of GDNF. The exogenous GDNF promoted differentiation of sensory and motor-derived SCs back to their native phenotypes, as demonstrated by decreased proliferation after 7days and increased expression of S100Ββ and phenotype-specific markers. Furthermore, inhibiting Fyn with Src family kinase inhibitors, PP2 and SU6656, and siRNA-mediated knockdown of Fyn reduced GDNF-stimulated differentiation of sensory and motor-derived SCs. These results demonstrate that activating Fyn is necessary for GDNF-stimulated differentiation of femoral nerve-derived SCs into their native phenotypes in vitro. Therefore GDNF could be incorporated into SC-based therapies to promote differentiation of SCs into their native phenotype to improve functional nerve regeneration.

Indexed as

AnimalsCell DifferentiationCell ProliferationCells, CulturedCoculture TechniquesDose-Response Relationship, DrugEnzyme InhibitorsFemoral NerveGene Expression RegulationGlial Cell Line-Derived Neurotrophic FactorNerve Tissue ProteinsNeurogliaPhenotypePhosphorylationRatsSchwann CellsEnzyme InhibitorsGlial Cell Line-Derived Neurotrophic FactorNerve Tissue Proteinssrc-Family KinasesCell transplantationDifferentiationFynNerve regenerationPeripheral nerve

Identifiers

PMID24731946
PMCPMC4065822
OpenAlexW1987828115

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.